This activity focuses on key operational and administrative considerations related to the use of viral vector gene therapies in hospitals and health systems. The content for this activity is based on questions and comments from participants at a recent educational symposium on this topic.

Learning Objectives

  • Review issues related to the preparation and safe handling of viral vector gene therapies.
  • Examine administrative considerations related to introducing viral vector gene therapies into a health system.
     

Faculty

John Petrich, B.S.Pharm., M.S.
Investigational Drug Service Manager
Cleveland Clinic
Cleveland, Ohio

Michael Storey, Pharm.D., M.S., BCPS
Medication Use and Formulary Coordinator
Nationwide Children’s Hospital
Columbus, Ohio

Target Audience

This activity was planned to meet the educational needs of pharmacists in hospitals and health systems involved with investigational drugs, drug information, and formulary management.

Format

This activity features slide presentations, active learning, and questions/discussion with faculty. View the system requirements.

Disclosures

In accordance with ACCME and ACPE Standards for Commercial Support, ASHP policy requires that all faculty, planners, reviewers, staff, and others in a position to control the content of this presentation disclose their financial relationships.

In this activity, only the individual below has disclosed a relevant financial relationship.  No other persons associated with this presentation have disclosed any relevant financial relationships.

Michael Storey, Pharm.D., M.S., BCPS

  • AveXis, Inc.: advisory board

Products that have not received FDA approval will be discussed during this presentation.

Claim CE Within 60 Days

Participants should claim CE credit for this home-study activity only if they have not claimed credit for the live activity.

To receive CE credit, complete the steps below within 60 days of completing the activity.

  1. View entire presentation and answer all polling questions.
  2. Click "Complete Activity" on the last slide to link to complete the assessment and evaluation.
  3. Verify credits were successfully transferred to CPE Monitor before the ACPE 60-day deadline by checking your NABP eProfile account.

After the 60-day deadline, ASHP will no longer be able to report credit(s).

CPE Information

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

ACPE #: 0204-0000-19-402-H01-P
Release Date: May 1, 2019
Expiration Date: May 31, 2020
Activity Type: Application-based
CE Credits: 1.0 hour
Activity Fee: Free of charge